Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 2 results found. Search for [ antiviral drug Virafin ]

Results 1 to 2 of 2
BusinessToday.In
April 26, 2021
As per a press release from the Hyderabad-based company, pre-clinical data has proven that Molnupiravir has broad anti-influenza activity, comprising highly potent inhibition of SARS-CoV-2 replication


BusinessToday.In
April 23, 2021
Zydus Cadila stated that 91.15 per cent of patients who were treated with the antiviral Virafin were RT-PCR negative by Day 7. The treatment also reduces hours of supplemental oxygen in patients


PAGES 1 OF 1